Drs Kathy Miller and Reshma Jagsi on the reasons behind practitioners' reluctance to omit radiation therapy in older patients.

A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman.

New research explores the risk/benefit profile of reproductive hormone therapy in menopausal women with migraine.

Some think it's time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017.

Dr George Lundberg urges discussion on modern sexual ethics.

The latest surveillance report reveals that sexually transmitted infections are again on the rise.

Dr Andrew Kaunitz comments on new studies that look at opioid prescribing in obstetrics and gynecology.

Hormone therapy must be discussed and individualized for each patient in order to achieve the best outcome for treating menopause.

Does this COX-2 inhibitor alter breast cancer risk? Dr Kathy Miller discusses the results of the REACT trial with its primary investigator, Dr Charles Coombes.

Dr Andrew Kaunitz disputes the recent findings from a Danish breast cancer risk study that primarily studied women in a lower-risk group.